These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13764266)

  • 1. The effect of oxidation and reduction on the infectivity of poliomyelitis virus.
    LUND E; LYCKE E
    Arch Gesamte Virusforsch; 1961; 11():100-10. PubMed ID: 13764266
    [No Abstract]   [Full Text] [Related]  

  • 2. The neutralization of the mouse-adapted poliomyelitis virus by the sera of patients, family contacts, and normal children in Los Angeles.
    PAIT CF; KESSEL JF; GROSSMAN P
    Am J Hyg; 1948 May; 47(3):335-44. PubMed ID: 18861403
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxidation in thermoinactivation of poliovirus.
    POHJANPELTO P
    Virology; 1962 Jan; 16():92-4. PubMed ID: 14487407
    [No Abstract]   [Full Text] [Related]  

  • 4. Inactivation of poliomyelitis virus by chlorination at different oxidation potentials.
    LUND E
    Arch Gesamte Virusforsch; 1961; 11():330-42. PubMed ID: 14467343
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic classification of poliomyelitis viruses. III. Results obtained with the method of neutralization with prototype sera. C. Studies from the University of Kansas on twenty-five strains.
    WENNER HA; RABE EF
    Am J Hyg; 1951 Sep; 54(2):243-54. PubMed ID: 14877804
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic classification of poliomyelitis viruses. III. Results obtained with the method of neutralization with prototype sera. D. Studies from the University of Southern California on sixteen strains.
    KESSELL JF; PAIT CF; KOKKO UP
    Am J Hyg; 1951 Sep; 54(2):251-4. PubMed ID: 14877805
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations on serological epidemiology antibodies to the Lansing strain of poliomyelitis virus in sera from Alaskan eskimos.
    PAUL JR; RIORDAN JR
    Am J Hyg; 1950 Sep; 52(2):202-12. PubMed ID: 14771042
    [No Abstract]   [Full Text] [Related]  

  • 8. Infectivity of murine SK strain of poliomyelitis virus.
    SCHULTZ EW; WHITE SC
    Proc Soc Exp Biol Med; 1948 Jun; 68(2):266-74. PubMed ID: 18869315
    [No Abstract]   [Full Text] [Related]  

  • 9. Purified human poliomyelitis virus; infectivity for cynomolgus monkeys.
    STULBERG CS; SLATER EA
    Proc Soc Exp Biol Med; 1948 Jun; 68(2):282-4. PubMed ID: 18869319
    [No Abstract]   [Full Text] [Related]  

  • 10. Infectivity of ribonucleic acid of poliovirus on HeLa cell mono-layers.
    ALEXANDER HE; KOCH G; MOUNTAIN IM; SPRUNT K; VAN DAMME O
    Virology; 1958 Feb; 5(1):172-3. PubMed ID: 13519758
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the interrelationship between the blood-brain barrier and entry of viruses into the central nervous system. I. The effect of carbon dioxide on type II poliovirus infection in mice.
    SELLERS MI; LAVENDER JF
    J Exp Med; 1962 Jan; 115(1):107-30. PubMed ID: 13910469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the inhibitory action in vitro of guanidine on poliomyelitis virus. XIV. Infectivity of ribonucleic acid extracted from a strain of guanidine-resistant poliovirus 1].
    LODDO B; MUNTONI S; FERRARI W
    Boll Soc Ital Biol Sper; 1963 Jan; 39():6-8. PubMed ID: 13931217
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological properties of ribonucleic acid from virulent and attenuated poliovirus.
    GERBER P; KIRSCHSTEIN R
    J Exp Med; 1960 Apr; 111(4):525-32. PubMed ID: 13704559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectivity of polio virus ribonucleic acid for embryonated eggs and unsusceptible cell lines.
    DE SOMER P; PRINZIE A; SCHONNE E
    Nature; 1959 Aug; 184(Suppl 9)():652-3. PubMed ID: 13815063
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous infectivity of type 2 poliomyelitis virus in mice.
    KRECH U
    Proc Soc Exp Biol Med; 1954 Jul; 86(3):488-91. PubMed ID: 13194699
    [No Abstract]   [Full Text] [Related]  

  • 17. Mixed infection with type 2 poliomyelitis virus and Columbia SK group virus in man; an attempt to explain any relation of viruses of the Columbia SK group to human poliomyelitis.
    VERLINDE JD; MOLRON JH
    Antonie Van Leeuwenhoek; 1954; 20(1):129-40. PubMed ID: 13159177
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of assay conditions on infectivity of heated poliovirus.
    KOCH G
    Virology; 1960 Dec; 12():601-3. PubMed ID: 13757324
    [No Abstract]   [Full Text] [Related]  

  • 19. Infectivity of ribonucleic acid from poliovirus in human cell monolayers.
    ALEXANDER HE; KOCH G; MOUNTAIN IM; VAN DAMME O
    J Exp Med; 1958 Oct; 108(4):493-506. PubMed ID: 13575680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of infection with poliovirus and other viruses in cases of aseptic meningitis (nonparalytic poliomyelitis) in Sheffield in 1954.
    TYRRELL DA; BALDUCCI D; SNELL B; ZAIMAN TE
    J Hyg (Lond); 1957 Dec; 55(4):457-63. PubMed ID: 13491833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.